Yuan‐Hung Kuo

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis

Yuan‐Hung Kuo, Sheng‐Nan Lu, Chao‐Long Chen et al. · European Journal of Cancer · 2010 · 98 citations

Medicine, Internal Medicine, Oncology +16

A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial

Wei‐Chen Tai, Chih‐Ming Liang, Chung‐Mou Kuo et al. · Journal of Antimicrobial Chemotherapy · 2019 · 94 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease

Yu-Chieh Tsai, Wei‐Chen Tai, Chih‐Ming Liang et al. · Journal of Microbiology Immunology and Infection · 2024 · 89 citations · Full text

Life Sciences, Immunology, Microbiology +17

The Efficacy of Second‐Line Anti‐<i>Helicobacter pylori</i> Therapy Using an Extended 14‐Day Levofloxacin/Amoxicillin/Proton‐Pump Inhibitor Treatment – A Pilot Study

Seng‐Kee Chuah, Wei‐Chen Tai, Pin‐I Hsu et al. · Helicobacter · 2012 · 75 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Hepatocellular Carcinoma Surveillance at 4- vs. 12-Month Intervals for Patients With Chronic Viral Hepatitis: A Randomized Study in Community

Jing‐Houng Wang, Kuo‐Chin Chang, Kwong‐Ming Kee et al. · The American Journal of Gastroenterology · 2013 · 75 citations

Medicine, Community Health, Oncology +14